会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Methods of enumerating receptor molecules for specific binding partners
on formed bodies and in solution
    • 列举形成体和溶液中特异性结合配偶体的受体分子的方法
    • US5814468A
    • 1998-09-29
    • US624014
    • 1996-03-27
    • Olavi SiimanAlexander BurshteynOrlando ConcepcionMeryl Forman
    • Olavi SiimanAlexander BurshteynOrlando ConcepcionMeryl Forman
    • G01N33/566G01N33/533C12Q1/70
    • G01N33/566
    • This invention relates generally to using fluorescent markers (labelled antibodies) and flow cytometry to enumerate the average number of receptors (antigen) on formed bodies (cells) in whole blood, and to evaluate the specific binding constant of the marker for the particular receptors. Mean channel fluorescence intensities of equilibrated marker-cell suspension mixtures, total concentrations of marker, and targeted cell counts obtained by established procedures are used to complete the analyses. The invention further describes a competitive binding assay between marker and unlabelled antibody for receptors shed from the surface of formed bodies into solution and receptors on the formed bodies to analyze for receptors in solution. Moreover, competitive binding assays between marker and unlabelled antibody for receptors on formed bodies in whole blood are described for determination of relative, specific, and average binding constants of unlabelled/labelled antibody for targeted receptors.
    • 本发明一般涉及使用荧光标记(标记抗体)和流式细胞术来列举全血中成体体(细胞)上的受体(抗原)的平均数目,并评估特定受体的标记物的特异结合常数。 平衡的标记 - 细胞悬浮液混合物的平均通道荧光强度,通过建立的程序获得的标记物的总浓度和靶细胞计数用于完成分析。 本发明进一步描述了标记物与未标记抗体之间的竞争性结合测定法,用于从形成体表面转移到溶液中的受体和形成体上的受体以分析溶液中的受体。 此外,描述了用于确定未标记/标记的靶向受体抗体的相对,特异性和平均结合常数的标记物和未标记抗体之间在全血中形成体上的受体的竞争结合测定。